| Literature DB >> 18775674 |
Thomas Klonisch1, Emilia Wiechec, Sabine Hombach-Klonisch, Sudharsana R Ande, Sebastian Wesselborg, Klaus Schulze-Osthoff, Marek Los.
Abstract
Rapid advances in the cancer stem cell (CSC) field have provided cause for optimism for the development of more reliable cancer therapies in the future. Strategies aimed at efficient targeting of CSCs are becoming important for monitoring the progress of cancer therapy and for evaluating new therapeutic approaches. Here, we characterize and compare the specific markers that have been found to be present on stem cells, cancer cells and CSCs in selected tissues (colon, breast, liver, pancreas and prostate). We then discuss future directions of this intriguing new research field in the context of new diagnostic and therapeutic opportunities.Entities:
Mesh：
Substances：
Year: 2008 PMID： 18775674 DOI： 10.1016/j.molmed.2008.08.003
Source DB: PubMed Journal: Trends Mol Med ISSN： 1471-4914 Impact factor: 11.951